Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Now that’s changing. So-called photon-counting CT scanners use AI and advanced semiconductors to detect previously invisible spinal leaks, enabling treatment and often leading to full recovery.